A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

1996 New England Journal of Medicine 1,080 citations

Abstract

Treatment with zidovudine plus didanosine, zidovudine plus zalcitabine, or didanosine alone slows the progression of HIV disease and is superior to treatment with zidovudine alone. Antiretroviral therapy can improve survival in patients with 200 to 500 CD4 cells per cubic millimeter.

Keywords

MedicineNucleosideHuman immunodeficiency virus (HIV)Nucleoside analogueVirologyCombination therapyYoung adultVirusInternal medicineImmunologyBiology

Affiliated Institutions

Related Publications

Publication Info

Year
1996
Type
article
Volume
335
Issue
15
Pages
1081-1090
Citations
1080
Access
Closed

External Links

Citation Metrics

1080
OpenAlex

Cite This

Scott M. Hammer, David Katzenstein, Michael D. Hughes et al. (1996). A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter. New England Journal of Medicine , 335 (15) , 1081-1090. https://doi.org/10.1056/nejm199610103351501

Identifiers

DOI
10.1056/nejm199610103351501